Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

COOPER COMPANIES Aktie

 >COOPER COS Aktienkurs 
61.84 EUR    (TradegateBSX)
Ask: 62.46 EUR / 96 Stück
Bid: 61.22 EUR / 98 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
COOPER COS Aktie über LYNX handeln
>COOPER COS Performance
1 Woche: -3,5%
1 Monat: +6,9%
3 Monate: +10,4%
6 Monate: -12,9%
1 Jahr: +0,6%
laufendes Jahr: -11,7%
>COOPER COMPANIES Aktie
Name:  COOPER COMPANIES
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US2166485019 / A402VX
Symbol/ Ticker:  CP60 (Frankfurt) / COO (NASDAQ)
Kürzel:  FRA:CP60, ETR:CP60, CP60:GR, NASDAQ:COO
Index:  -
Profil:  The Cooper Companies, Inc. is a global medical device company focused on eyecare and women’s health, headquartered in San Ramon, California. The business operates through two main segments: CooperVision and CooperSurgical. CooperVision develops, ma..
>Volltext..
Marktkapitalisierung:  12062.62 Mio. EUR
Unternehmenswert:  14042.79 Mio. EUR
Umsatz:  3721.99 Mio. EUR
EBITDA:  1015.32 Mio. EUR
Nettogewinn:  207.43 Mio. EUR
Gewinn je Aktie:  1.05 EUR
Schulden:  2164.17 Mio. EUR
Liquide Mittel:  122.27 Mio. EUR
Operativer Cashflow:  838.33 Mio. EUR
Bargeldquote:  0.08
Umsatzwachstum:  2.42%
Gewinnwachstum:  -45.04%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Div. Historie:  26.07.23 - 0.00160875€
20.01.23 - 0.00160875€
>weitere anzeigen...
Insiderhandel -
Suchwörter:  COOPER COMPANIES, COOPERCOMPANIES, COOPER COS
Letzte Datenerhebung:  26.07.26
>COOPER COS Kennzahlen
Aktien/ Unternehmen:
Aktien: 195.03 Mio. St.
Frei handelbar: 99.33%
Rückkaufquote: 2.49%
Mitarbeiter: 15000
Umsatz/Mitarb.: 0.24 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 15.97%
Bewertung:
KGV: 60.7
KGV lG: 15.04
KUV: 3.21
KBV: 1.7
PEG-Ratio: -
EV/EBITDA: 13.83
Rentabilität:
Bruttomarge: 60.93%
Gewinnmarge: 5.57%
Operative Marge: 18.19%
Managementeffizenz:
Gesamtkaprendite: 1.89%
Eigenkaprendite: 2.85%
>COOPER COS Peer Group
Gesundheit, Augenmedizin/ Sehhilfen, Medizinprodukte & -technik/ Implantate/ Wundpflege
 
16.07.26 - 20:45
Reasons to Retain Cooper Companies Stock in Your Portfolio for Now (Zacks)
 
Cooper Companies' premium contact lenses, restructuring gains and product launches support growth despite regional and competitive headwinds....
30.06.26 - 22:18
CooperCompanies Releases 2025 Corporate Sustainability Report with Scope 3 Emissions Disclosure (GlobeNewswire EN)
 
SAN RAMON, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, released today its 2025 Corporate Sustainability Report. The report showcases the company's commitment to people and planet, supported by expanded performance metrics and continued progress on sustainability priorities. A key milestone in this year's report is the company's first-time disclosure of Scope 3 greenhouse gas emissions, enhancing transparency and strengthening its sustainability reporting....
29.06.26 - 17:30
Here′s Why The Cooper Companies (COO) is a Strong Growth Stock (Zacks)
 
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores....
23.06.26 - 17:31
Here′s Why The Cooper Companies (COO) is a Strong Momentum Stock (Zacks)
 
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores....
16.06.26 - 14:54
Cooper Companies Stock: Is COO Underperforming the Healthcare Sector? (Barchart)
 
Um den gesamten Artikel unter newsbreak.com zu lesen, klicken Sie bitte auf die Überschrift...
09.06.26 - 17:30
Why The Cooper Companies (COO) is a Top Growth Stock for the Long-Term (Zacks)
 
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service....
08.06.26 - 16:45
The Cooper Companies (COO) Reliance on International Sales: What Investors Need to Know (Zacks)
 
Evaluate The Cooper Companies' (COO) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance....
05.06.26 - 19:00
COO Stock Rises on Q2 Earnings Beat, FY26 Revenue Guidance Trimmed (Zacks)
 
Cooper Companies beats Q2 EPS and sales estimates as CooperVision and CooperSurgical hit record revenues, even with a GAAP loss from recall litigation....
05.06.26 - 17:12
Cooper Companies: Aktie steigt nach starken Quartalszahlen und strategischem Update (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
05.06.26 - 13:54
CooperCompanies rises on Q2 beat despite net loss (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
05.06.26 - 06:27
Cooper Companies forecasts $4.28B-$4.32B fiscal 2026 revenue while advancing CooperSurgical review (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
05.06.26 - 01:45
Here′s What Key Metrics Tell Us About The Cooper Companies (COO) Q2 Earnings (Zacks)
 
Although the revenue and EPS for The Cooper Companies (COO) give a sense of how its business performed in the quarter ended April 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers....
05.06.26 - 01:00
The Cooper Companies (COO) Beats Q2 Earnings and Revenue Estimates (Zacks)
 
The Cooper Companies (COO) delivered earnings and revenue surprises of +9.67% and +2.57%, respectively, for the quarter ended April 2026. Do the numbers hold clues to what lies ahead for the stock?...
05.06.26 - 00:48
Full Transcript: Cooper Companies Q2 2026 Earnings Call (Benzinga)
 
Importance Rank:  1 read more...
05.06.26 - 00:30
Cooper Companies übertrifft Q2-Prognosen 2026, Aktie legt zu (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
04.06.26 - 23:42
Cooper Companies Posts Q2 Loss Hurt By One-Time Litigation Charge, Revenue Rises 8% (AFX)
 
WASHINGTON (dpa-AFX) - Cooper Companies, Inc. (COO) on Thursday posted a net loss due to a substantial litigation-related charge tied to a 2023 product recall. However, the company reported higher......
04.06.26 - 22:27
The Cooper Companies Non-GAAP EPS of $1.21 beats by $0.12, revenue of $1.08B beats by $30M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
04.06.26 - 22:18
CooperCompanies Announces Second Quarter 2026 Results (GlobeNewswire EN)
 
SAN RAMON, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal second quarter ended April 30, 2026....
03.06.26 - 23:39
The Cooper Companies Q2 2026 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
03.06.26 - 20:30
The Cooper Companies Gears Up to Post Q2 Earnings: What′s in Store? (Zacks)
 
CooperVision momentum and MyDay/MiSight adoption are likely to fuel COO's Q2, but Japan softness and fertility uncertainty remain key watch points....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Die Frucht eines Luxuslebens ist Luxus. - Henry David Thoreau
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!